Advm Stock Insider Trading

Healthcare > Biotechnology

Buy ADVM

*Your capital is at risk

$4.36

+0 (+0%)

At Close: Mar 06, 2026

ADVM Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -77.06. In total, the insiders bought 1.26M and sold 2.94M ADVM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-77.06
● Buy	1.26M shares
● Sell	2.94M shares
9% Buy Activity Moderate Positive Correlation
Sell Signal High Confidence Dec 09, 2025 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -77.06. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (9% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Machado Patrick Director	Director	13 590 Value: $31.5K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Seyedkazemi Setareh Chief Development Officer	Officer	8 500 Value: $86.2K
Dec 09, 2025 Buy	Common Stock - Performance Stock Units A-Award	Seyedkazemi Setareh Chief Development Officer	Officer	85 000 Value: $370.6K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Machado Patrick Director	Director	5 250 Value: $194.3K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Kiss Szilard Director	Director	2 500 Value: $24.0K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Fischer Laurent CEO, President And Director	CEO / President	200 000 Value: $1.43M
Dec 09, 2025 Sell	Common Stock U-Tender	Fischer Laurent CEO, President And Director	CEO / President	351 513 Value: $1.25M
Dec 09, 2025 Sell	Common Stock - Performance Stock Units U-Tender	Fischer Laurent CEO, President And Director	CEO / President	522 666 Value: $1.86M
Dec 09, 2025 Sell	Common Stock - Restricted Stock Units U-Tender	Fischer Laurent CEO, President And Director	CEO / President	25 000 Value: $89.0K
Dec 09, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Fischer Laurent CEO, President And Director	CEO / President	150 000 Value: $630.0K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Fischer Laurent CEO, President And Director	CEO / President	110 420 Value: $1.12M
Dec 09, 2025 Buy	Common Stock - Performance Stock Units A-Award	Soparkar Peter Chief Operating Officer	C-Suite Officer	150 000 Value: $654.0K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Soparkar Peter Chief Operating Officer	C-Suite Officer	39 476 Value: $400.3K
Dec 09, 2025 Sell	Common Stock U-Tender	Soparkar Peter Chief Operating Officer	C-Suite Officer	80 189 Value: $285.5K
Dec 09, 2025 Sell	Common Stock - Restricted Stock Units U-Tender	Soparkar Peter Chief Operating Officer	C-Suite Officer	13 125 Value: $46.7K
Dec 09, 2025 Sell	Common Stock - Performance Stock Units U-Tender	Soparkar Peter Chief Operating Officer	C-Suite Officer	157 333 Value: $560.1K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Soparkar Peter Chief Operating Officer	C-Suite Officer	40 000 Value: $300.0K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Soparkar Peter Chief Operating Officer	C-Suite Officer	64 394 Value: $460.4K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Soparkar Peter Chief Operating Officer	C-Suite Officer	78 750 Value: $330.8K
Dec 09, 2025 Buy	Common Stock - Performance Stock Units A-Award	Ozden Rabia Gurses Chief Medical Officer	Officer	85 000 Value: $370.6K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Ozden Rabia Gurses Chief Medical Officer	Officer	4 000 Value: $40.6K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Ozden Rabia Gurses Chief Medical Officer	Officer	85 000 Value: $622.2K
Dec 09, 2025 Sell	Common Stock - Performance Stock Units U-Tender	Ozden Rabia Gurses Chief Medical Officer	Officer	85 000 Value: $302.6K
Dec 09, 2025 Sell	Stock Option (Right to Buy) D-Return	Ozden Rabia Gurses Chief Medical Officer	Officer	48 750 Value: $204.8K
Dec 09, 2025 Sell	Common Stock - Restricted Stock Units U-Tender	Ozden Rabia Gurses Chief Medical Officer	Officer	8 125 Value: $28.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ADVM

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with U...

Read Full Profile Here